Intravenous administration of anakinra in children with macrophage activation syndrome

Abstract Background Subcutaneous anakinra is an interleukin-1 inhibitor used to treat juvenile idiopathic arthritis. Recent reports suggest anakinra can be a valuable addition to the treatment of COVID-19 associated cytokine storm syndrome and the related multisystem inflammatory syndrome (MIS-C) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Omkar Phadke (Author), Kelly Rouster-Stevens (Author), Helen Giannopoulos (Author), Shanmuganathan Chandrakasan (Author), Sampath Prahalad (Author)
Format: Book
Published: BMC, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available